Global Blood Therapeutics, Inc.
Methods of treatment
Last updated:
Abstract:
This disclosure relates to use of certain aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease such as scleroderma, lupus, arthritis and related conditions in a mammal.
Status:
Grant
Type:
Utility
Filling date:
16 May 2018
Issue date:
30 Jun 2020